All you should know about JN.1 Coronavirus sub-variant
Southcheck Network
All you should know about JN.1 Coronavirus sub-variant
Global Surge in JN.1
- JN.1 rapidly increasing worldwide.
- Current global prevalence: 27.1%
- 7,344 sequences submitted to GISAID from 41 countries.
JN.1 Hotspots
- France leads with 20.1% prevalence.
- USA follows with 14.2%.
- Other contributors: Singapore (12.4%), Canada (6.8%), UK (5.6%), Sweden (5%).
Key JN.1 Symptoms
- CDC notes mild gastrointestinal issues (abdominal pain, diarrhea).
- Common viral symptoms include fever, sore throat, cough.
- Breathlessness is a concern, despite generally mild symptoms.
Expert Insights and Recommendations
- Dr. Kiran Madhala, Nizamabad Government Hospital, identifies JN.1 as a sub-variant of Omicron’s BA.2.86.
- Urges vigilance, Covid-appropriate behavior, especially for vulnerable populations.